Jan 23 (Reuters) - Array Biopharma Inc:
* ARRAY BIOPHARMA SAYS PIERRE FABRE MEDICAMENT, REQUESTED THAT MARKETING AUTHORIZATION APPLICATIONS FOR BINIMETINIB MONOTHERAPY BE WITHDRAWN
* ARRAY BIOPHARMA - WITHDRAWAL OF MAA APPLICATIONS FOR BINIMETINIB MONOTHERAPY IN NRAS-MUTANT MELANOMA REQUESTED IN EU, SWITZERLAND AND AUSTRALIA
* ARRAY BIOPHARMA - PIERRE FABRE MEDICAMENT IS ARRAY'S COLLABORATION PARTNER Source text: ( bit.ly/2DGm2Ug ) Further company coverage:
 